Over the last three days, A.I.dvisor has detected that NOVA's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend. For traders, this could mean going long the stock or exploring call options in the next month. A.I.dvisor backtested this indicator and found 95 similar cases, 88 of which were successful. Based on this data, the odds of success are 90%. Current price $40.97 is above $30.77 the highest resistance line found by A.I. Throughout the month of 10/28/20 - 11/30/20, the price experienced a +53% Uptrend. During the week of 11/20/20 - 11/30/20, the stock enjoyed a +16% Uptrend growth.
Bullish Trend Analysis The Moving Average Convergence Divergence (MACD) for NOVA just turned positive on November 05, 2020. Looking at past instances where NOVA's MACD turned positive, the stock continued to rise in 8 of 9 cases over the following month. The odds of a continued upward trend are 89%.
NOVA moved above its 50-day Moving Average on November 03, 2020 date and that indicates a change from a downward trend to an upward trend.
The 10-day Moving Average for NOVA crossed bullishly above the 50-day moving average on November 04, 2020. This indicates that the trend has shifted higher and could be considered a buy signal. In 4 of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +13.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where NOVA advanced for three days, in 93 of 100 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The Aroon Indicator entered an Uptrend today. In 88 of 95 cases where NOVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.